Navigation Links
Bionovo Announces Second Quarter 2009 Highlights and Financial Results
Date:8/10/2009

EMERYVILLE, Calif., Aug. 10 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced second quarter highlights and financial results for the three months ended June 30, 2009.

Company Highlights

    -- Further results from the phase 1B clinical trial of Bezielle (BZL101)
       in 27 patients with metastatic breast cancer showed Bezielle to be
       safe and well-tolerated with encouraging evidence of clinical activity
       in a heavily pretreated patient population - most importantly
       including:

       -- 31% had stable disease for more than 90 days;
       -- 13% had stable disease for more than 180 days;
       -- three patients had objective tumor regression;
       -- one patient had objective tumor regression while on Bezielle
          therapy for 449 days and continues to be stable off of study
          medication for over 600 days;
       -- a second patient continues to be stable for 832 days and has not
          started any new anticancer treatment;
       -- a third patient was stable without any new anticancer therapy for
          591 days;
       -- there were no deaths or serious adverse events that were attributed
          to Bezielle (BZL101); and
       -- the most common side effects associated with Bezielle (BZL101) were
          minor and gastrointestinal in nature.


       These results provide further evidence that Bezielle (BZL101) may
       provide an important option for women suffering from advanced breast
       cancer, an extremely difficult to treat subset of the breast cancer
       population.

    -- On the SERM platform, a peer-reviewed study published in the journal
       "Public Library of Science One" found that when comparing the gene
       expression induced by ERb compounds to that induced by est
'/>"/>
SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Mich. , June 29, 2015  New ... and American Stroke Association give hope for better ... who experience an acute ischemic stroke each year. ... the key products used in the clinical trials ... The new AHA/ASA guidelines strongly recommend endovascular therapy ...
(Date:6/29/2015)...  Nevro Corp. (NYSE: NVRO ), a global ... for the treatment of chronic pain, today announced that ... of Intersect ENT (NASDAQ: XENT ), has been ... 2015. For the last seven years, ... a company dedicated to improving the quality of life ...
(Date:6/29/2015)... ZIONA, Israel , June 29, 2015 ... TASE: BVXV) today announced positive preliminary results from its ... for a universal influenza vaccine. In this trial, M-001 ... 50 to 65, followed by an administration of the ... M-001 was found to be safe and well tolerated ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3
... YORK , June 24 Reportlinker.com announces that a new market research report ... Global Hernia Repair Devices ... http://www.reportlinker.com/p0209282/Global-Hernia-Repair-Devices-Industry.html , ... This report analyzes the Global market for Hernia Repair Devices in US$ Million by the ...
... June 24 Today the United ... (CDC) issued new and important guidelines on the detection ... of tuberculosis (TB). In these landmark guidelines, CDC advises ... now preferred over the 100+-year-old tuberculin skin test (TST) ...
Cached Medicine Technology:Reportlinker Adds Global Hernia Repair Devices Industry 2Reportlinker Adds Global Hernia Repair Devices Industry 3Reportlinker Adds Global Hernia Repair Devices Industry 4Reportlinker Adds Global Hernia Repair Devices Industry 5Reportlinker Adds Global Hernia Repair Devices Industry 6Reportlinker Adds Global Hernia Repair Devices Industry 7Reportlinker Adds Global Hernia Repair Devices Industry 8Reportlinker Adds Global Hernia Repair Devices Industry 9Reportlinker Adds Global Hernia Repair Devices Industry 10New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 2New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 3New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 4New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 5
(Date:6/29/2015)... , ... June 29, 2015 , ... With Urgent Care ... a partnership with the American Board of Urgent Care Medicine and the Medical Society ... 1 Credit™ to Urgent Care physicians and health care professionals. , According to Matthew ...
(Date:6/29/2015)... , ... June 29, 2015 , ... OR Manager announced ... revitalized look and feel, as well as a redesigned logo and weekly eLetter. The ... but is now more user-friendly and easier to navigate. , In addition to ...
(Date:6/29/2015)... ... 29, 2015 , ... The Food Safety and Technology Research ... Kong Polytechnic University (PolyU) has developed a new method for rapid authentication of ... a long-term issue in food safety, and becomes particularly important with the emergence ...
(Date:6/29/2015)... ... June 29, 2015 , ... DISC, a ... is a popular focus for corporate training seminars. As many as seventy percent ... training, foster teamwork, and increase productivity. , With the demand for in-house ...
(Date:6/29/2015)... ... June 29, 2015 , ... Wheel:Life, ... Travel Guide for Wheelchair Users as a new e-book on Amazon.com. Wheel:Life publications ... , These accessible travel suggestions were crowdsourced by the Get Out & Enjoy ...
Breaking Medicine News(10 mins):Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 3
... malady that many suffer from, it often breeds discomfort and ... to overcome it those struggling with this malady ... in causing bad breath//. In the absence of any clear-cut ... mouth rinses are usually resorted to. ,Statistics ...
... in the gray matter has offered an insight into a ... introduction – SELFISHNESS//. Bewildering all the same, why are some ... others believe in being the epitome of selflessness! ... at the front of the brain, termed as the dorsolateral ...
... caught between the devil and the deep sea, unable to ... of emergency mental// healthcare. The patient, a 17 year old ... form of counseling was attempted. ,The girl suffered ... suicide attempts. According to the mother, her daughter was ...
... According to the Idaho health officials, the kid who died ... E. coli strain in the tainted spinach that has caused ... boy, Kyle Allgood, from Chubbuck, Idaho, who died on Sept. ... bacteria outbreak that has sickened 192 people in the United ...
... first time issued Global Air Quality Guidelines on Thursday so ... million// people each year with most of the deaths occurring ... to enhance air quality in the cities. A statement issued ... 3,00,000 lives could be saved every year by bringing down ...
... Andhra Pradesh carry the HIV virus, which is passed on to ... (APSACS) has come to the aid of such infants, suffering HIV ... society strives to realize infant births sans HIV by the year ... country, the group has lined up the Telugu Network of HIV ...
Cached Medicine News:
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: